Article -> Article Details
| Title | Cystic Acne Market Scope, Product Estimates & Strategy Framework, Forecasts, 2017-2023 |
|---|---|
| Category | Fitness Health --> Mental Health |
| Meta Keywords | Cystic Acne Market |
| Owner | vinit |
| Description | |
| Cystic acne is a dangerous skin condition. It is the most
serious type of acne wherein the pores of the skin get blocked. This blockage
leads to infection or inflammation of the affected area of the skin. A new
report on the global cystic acne market, published by Market Research Future
(MRFR), scans this market to see a raise at 10% CAGR between 2017 and 2023. The most significant market driving factor for the global
cystic acne market growth is the rising prevalence of cystic acne conditions
both in developed and developing countries. The major market players in the
skincare industry and different research laboratories are involved in research
development (RD) to develop formulas for medicines or ointments provide better
treatment. Other factors contributing to the market growth include awareness
about skin infections, demand for better skincare remedy, and trend among
youngsters to be more conscious about their looks, increasing purchasing power
of consumers, and subsequently increasing sales of anti-acne ointments. Market Segmentation The global cystic
acne market segmentation encompasses end-user, causes,
long-term effects, and treatment type. MRFR’s take on the market surveys
various facets of the market in-depth. Regarding end-user, this market has been segmented into
clinics, hospitals, research laboratories, and others. The causes-based
segmentation of this market covers drugs/chemical side effects, hormonal
imbalances, occlusive skin products, and others. As per the long-term effects, the market has been segmented
into hypertrophic scarring, ice pick scars, larger pits on the skin, shallow
depressions, and others. By treatment type, the market has been segmented into
drainage extraction procedure, laser therapy, microdermabrasion, topical
medications, and others. Regional Segmentation A geographical outlining of the global cystic acne market
covers the Americas (North America South America), Asia Pacific, Europe, and
the Middle East Africa (MEA). The Americas region is dominating the global market as North
America alone is strong enough to generate maximum market revenue. Due to technological
advancements and availability of advanced medical facilities, North America is
a bigger regional market segment, compared to South America. North America is a
strong regional market segment due to the availability of well-developed
technology, the growing use of technology in medical sector, presence of key
market players, and increasing population with acne. American brands export
their products to other regions too. In North America, maximum revenue comes
from USA and Canada. In South America, the most vibrant economies are Argentina
and Brazil that can be important markets in the future. Europe is the second-largest market due to the availability
of funds for research and government support for RD. Due to the reasons that
are same as in the Americas, Western Europe is a bigger regional market than
Eastern Europe. The most powerful country-specific markets in Europe are
France, Germany, Italy, Spain, and the UK. An inspection of the remaining
countries in Western Europe featured in this report speculate the huge
contribution to market revenue from many other countries in this region with a
sizable revenue from Eastern Europe too. The Asia Pacific region is the fastest-growing regional
market due to the high healthcare expenditure and presence of rapidly growing
patient population. The governments of many Asian countries are focusing on
providing better medical treatment to the citizen of their countries for
improving their quality of life. Many market players in USA are trying capture
the maximum share in the emerging markets like China and India. Other important
country-specific markets in this region are Australia, Japan, and South Korea.
An evaluation of the remaining countries in the Asia Pacific region featured in
this report calculates the huge market revenue supply from some other
countries. In the MEA region, the market is small due to the ignorance
of diseases, limited screening, and poor access to treatment. Some of the key
country-specific markets in this region are Kuwait, Oman, Qatar, Saudi Arabia,
and the United Arab Emirates. A valuation of the remaining countries in the MEA
region featured in this report anticipates a decent contribution to market
revenue from some other countries. Key Players Big players in the global cystic acne market include Abbott
Laboratories (USA), Alma Lasers Inc. (Israel), Bristol-Myers Squibb Company
(USA), DUSA Pharmaceuticals Inc. (USA), GE Healthcare (UK), Herbert Waldmann
GmbH Co. KG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline
PLC (UK), Hexal AG (Germany), National Biological Corp. (USA), Pfizer Inc.
(USA), and Sylvan Company (USA). Latest Industry News
| |